publication . Article . Other literature type . 2018

Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak

Mariel A. Marlow; Manisha Patel; Kelly L. Moore; Mona Marin;
Open Access
  • Published: 12 Jan 2018 Journal: MMWR. Morbidity and Mortality Weekly Report, volume 67, pages 33-38 (issn: 0149-2195, eissn: 1545-861X, Copyright policy)
  • Publisher: Centers for Disease Control MMWR Office
Abstract
A substantial increase in the number of mumps outbreaks and outbreak-associated cases has occurred in the United States since late 2015 (1,2). To address this public health problem, the Advisory Committee on Immunization Practices (ACIP) reviewed the available evidence and determined that a third dose of measles, mumps, rubella (MMR) vaccine is safe and effective at preventing mumps. During its October 2017 meeting, ACIP recommended a third dose of a mumps virus-containing vaccine* for persons previously vaccinated with 2 doses who are identified by public health authorities as being part of a group or population at increased risk for acquiring mumps because of ...
Subjects
free text keywords: Health Information Management, Epidemiology, Health, Toxicology and Mutagenesis, Health(social science), General Medicine, Full Report, Public health, medicine.medical_specialty, medicine, Family medicine, Mumps virus, medicine.disease_cause, Outbreak, Risk assessment, Mumps vaccine, Population, education.field_of_study, education, Rubella, medicine.disease, Measles, business.industry, business
34 references, page 1 of 3

1. Clemmons NS, Redd S, Fiebelkorn AP, Mumps: July 2010–2015, 2016, and beyond. Presentation at the 47th National Immunization Conference; September 14, 2016; Atlanta, GA.

2. Clemmons NS, Lee AD, Lopez A, Reported mumps cases (Jan 2011–Jun 2017) and outbreaks (Jan 2016–Jun 2017) in the United States. Presentation at ID Week 2017; October 4–8, 2017; San Diego, CA.

3. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep 2013;62(No. RR-04).23760231 [PubMed]

4. CDC. Mumps vaccine.MMWR Morb Mortal Wkly Rep 1977;26:393–4.

5. CDC. Measles prevention.MMWR Suppl 1989;38:1–18.2513473 [PubMed]

6. Dayan GH, Quinlisk MP, Parker AA, Recent resurgence of mumps in the United States.N Engl J Med 2008;358:1580–9. 10.1056/NEJMoa0706589 18403766 [PubMed] [DOI]

7. CDC. Notice to readers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps.MMWR Morb Mortal Wkly Rep 2006;55:629–30.16761359 [PubMed]

8. Marin M. Update on mumps epidemiology, United States. Presentation at the Advisory Committee on Immunization Practices meeting; October 25–26, 2017; Atlanta, GA. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2017-10/mumps-02-marin-508.pdf

9. Clemmons N, Hickman C, Lee A, Marin M, Patel M. Mumps [chapter 9]. In: CDC. Manual for the surveillance of vaccine-preventable diseases. Atlanta, GA: US Department of Health and Human Services, CDC; 2018 https://www.cdc.gov/vaccines/pubs/surv-manual/chpt09-mumps.pdf

10. Sane J, Gouma S, Koopmans M, Epidemic of mumps among vaccinated persons, the Netherlands, 2009–2012.Emerg Infect Dis 2014;20:643–8. 10.3201/eid2004.131681 24655811 [OpenAIRE] [PubMed] [DOI]

11. Zamir CS, Schroeder H, Shoob H, Abramson N, Zentner G. Characteristics of a large mumps outbreak: clinical severity, complications and association with vaccination status of mumps outbreak cases.Hu m Vaccin Immunother 2015;11:1413–7. 10.1080/21645515.2015.1021522 25874726 [OpenAIRE] [PubMed] [DOI]

12. Cardemil CV, Dahl RM, James L, Effectiveness of a third dose of MMR vaccine for mumps outbreak control.N Engl J Med 2017;377:947–56. 10.1056/NEJMoa1703309 28877026 [OpenAIRE] [PubMed] [DOI]

13. Greenland K, Whelan J, Fanoy E, Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010.Vaccine 2012;30:4676–80. 10.1016/j.vaccine.2012.04.083 22579874 [OpenAIRE] [PubMed] [DOI]

14. Takla A, Böhmer MM, Klinc C, Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011.Hum Vaccin Immunother 2014;10:140–5. 10.4161/hv.26642 24091837 [OpenAIRE] [PubMed] [DOI]

15. Vygen S, Fischer A, Meurice L, Waning immunity against mumps in vaccinated young adults, France 2013.Euro Surveill 2016;21:30156. 10.2807/1560-7917.ES.2016.21.10.30156 26987576 [PubMed] [DOI]

34 references, page 1 of 3
Any information missing or wrong?Report an Issue